Exagen Inc. financial data

Symbol
XGN on Nasdaq
Industry
Services-Medical Laboratories
Location
1261 Liberty Way, Vista, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
EXAGEN DIAGNOSTICS INC (to 5/18/2017)
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 447 % -36.1%
Debt-to-equity 148 % +49.9%
Return On Equity -78.9 % +6.57%
Return On Assets -31.8 % +25.2%
Operating Margin -27.9 % +57.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.4M shares +3.13%
Common Stock, Shares, Outstanding 17.4M shares +3.11%
Entity Public Float 37.3M USD -39.4%
Common Stock, Value, Issued 17K USD 0%
Weighted Average Number of Shares Outstanding, Basic 18.2M shares +2.96%
Weighted Average Number of Shares Outstanding, Diluted 18.2M shares +2.96%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 56.7M USD +7.05%
Research and Development Expense 4.71M USD -36.9%
Costs and Expenses 72.5M USD -17.5%
Operating Income (Loss) -15.8M USD +54.7%
Net Income (Loss) Attributable to Parent -17.3M USD +50.7%
Earnings Per Share, Basic -0.97 USD/shares +52.2%
Earnings Per Share, Diluted -0.97 USD/shares +52.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.5M USD -22.2%
Accounts Receivable, after Allowance for Credit Loss, Current 11.7M USD -27.9%
Other Assets, Current 2.87M USD +73.9%
Assets, Current 40.8M USD -20.4%
Property, Plant and Equipment, Net 8.2M USD +71.8%
Operating Lease, Right-of-Use Asset 2.85M USD -35.3%
Goodwill 0 USD -100%
Other Assets, Noncurrent 513K USD -17.3%
Assets 49.3M USD -23.2%
Accounts Payable, Current 2.33M USD +78%
Accrued Liabilities, Current 5.66M USD -4.64%
Liabilities, Current 9.45M USD +9.8%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 2.23M USD -43.2%
Other Liabilities, Noncurrent 219K USD -63.3%
Liabilities 31.7M USD -1.72%
Retained Earnings (Accumulated Deficit) -286M USD -6.46%
Stockholders' Equity Attributable to Parent 17.6M USD -44.9%
Liabilities and Equity 49.3M USD -23.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.04M USD +7.27%
Net Cash Provided by (Used in) Financing Activities -100K USD -61.3%
Net Cash Provided by (Used in) Investing Activities -86K USD +78.3%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 17.4M shares +3.11%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.23M USD +9.61%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.7M USD -22.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 434K USD -3.34%
Deferred Tax Assets, Valuation Allowance 42.9M USD +11.3%
Deferred Tax Assets, Gross 44M USD +10.2%
Operating Lease, Liability 3.74M USD -32.5%
Payments to Acquire Property, Plant, and Equipment 86K USD -78.3%
Lessee, Operating Lease, Liability, to be Paid 4.28M USD -35.1%
Property, Plant and Equipment, Gross 13.3M USD +53.9%
Operating Lease, Liability, Current 1.04M USD -6.25%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.28M USD -14.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.24M USD -14.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 541K USD -48.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.32M USD -14.2%
Deferred Tax Assets, Operating Loss Carryforwards 32.5M USD +9.03%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 445K USD -71.9%
Operating Lease, Payments 282K USD
Additional Paid in Capital 303M USD +1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2M USD -4.76%
Deferred Tax Assets, Net of Valuation Allowance 1.1M USD -22%
Share-based Payment Arrangement, Expense 2.77M USD -28.2%
Interest Expense 2.25M USD -9.73%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%